Yes, based on Phase 2 clinical trial data
Any AOD 9604 that is available carries many of the risks associated with unapproved peptide therapy, including potential quality concerns (e.g., mislabeling, purity, etc.)
The ingredients are: Water, Dipropylene Glycol, Glycerin, Pentylene Glycol, 1,2-hexanediol, Niacinamide, Ammonium Acryloyldimethyltaurate/vp Copolymer, Polyacrylate Crosspolymer-6, Butylene Glycol, Xanthan Gum, Ethylhexylglycerin, Adenosine, Polyquaternium-51, Disodium EDTA, Citric Acid, Caprylyl Glycol, Betaine, T-butyl Alcohol, Sodium Pca, Sodium Lactate, Acetyl Hexapeptide-8, Copper Tripeptide-1, Pca, Sh-polypeptide-121, Serine, Alanine, Allantoin, Sodium Hyaluronate, Acetyl Glucosamine, Glycine, Glutamic Acid, Lysine Hcl, Threonine, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Arginine, Tocopherol, Oligopeptide-68, Proline, Dextran, Palmitoyl Tripeptide-8, Glycine Soja (soybean) Oil, Hydrogenated Lecithin, Potassium Sorbate, Sodium Oleate
250 mm
A medida que los pacientes pierden peso, frecuentemente reportan mayor facilidad para realizar actividades cotidianas, mejor calidad del sueo y mayor motivacin para mantenerse activos